Very Low-Dose Anti-Thymocyte Globulin in HLA-Matched PBSCT – Results of a Phase II Study (JSCT-ATG 15) – | Zendy

Souichi Shiratori | Zendy; Junichi Sugita | Zendy; Shuichi Ohta | Zendy; Senji Kasahara | Zendy; Jun Ishikawa | Zendy; Heiwa Kanamori | Zendy; Yoshiki Hayashi | Zendy; Goichi Yoshimoto | Zendy; Tetsuya Eto | Zendy; Hiromi Iwasaki | Zendy; Keitaro Matsuo | Zendy; Mine Harada | Zendy; Takanori Teshima | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Very Low-Dose Anti-Thymocyte Globulin in HLA-Matched PBSCT – Results of a Phase II Study (JSCT-ATG 15) –

Author(s) -

Souichi Shiratori,

Junichi Sugita,

Shuichi Ohta,

Senji Kasahara,

Jun Ishikawa,

Heiwa Kanamori,

Yoshiki Hayashi,

Goichi Yoshimoto,

Tetsuya Eto,

Hiromi Iwasaki,

Keitaro Matsuo,

Mine Harada,

Takanori Teshima

Publication year - 2020

Publication title -

biology of blood and marrow transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.301

H-Index - 120

eISSN - 1523-6536

pISSN - 1083-8791

DOI - 10.1016/j.bbmt.2019.12.735

Subject(s) - medicine , anti thymocyte globulin , thymoglobulin , cumulative incidence , gastroenterology , clinical endpoint , graft versus host disease , incidence (geometry) , calcineurin , hematopoietic stem cell transplantation , transplantation , methotrexate , immunology , tacrolimus , randomized controlled trial , physics , optics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research